Synonyms: CTA A1 | MDL 62873 | MDL-62873 | MDL62873
Compound class:
Peptide or derivative
Comment: Mideplanin is an experimental glycopeptide antibacterial, that is a semisynthetic amide derivative of teicoplanin [2].
|
References |
1. Bartoloni A, Colao MG, Orsi A, Dei R, Giganti E, Parenti F. (1990)
In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile. J Antimicrob Chemother, 26 (5): 627-33. [PMID:1688341] |
2. Biavasco F, Lupidi R, Varaldo PE. (1992)
In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873. Antimicrob Agents Chemother, 36 (2): 331-8. [PMID:1534977] |
3. Jones RN, Goldstein FW, Zhou XY. (1991)
Activities of two new teicoplanin amide derivatives (MDL 62211 and MDL 62873) compared with activities of teicoplanin and vancomycin against 800 recent staphylococcal isolates from France and the United States. Antimicrob Agents Chemother, 35 (3): 584-6. [PMID:1828137] |